Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux

Nat Chem Biol. 2022 Oct;18(10):1162. doi: 10.1038/s41589-022-01146-9.

Sanna N Masud^#^{1

2

3}, Megha Chandrashekhar^#^{1

2

4}, Michael Aregger^{2

5}, Guihong Tan², Xiaoyu Zhang², Patricia Mero^{2

3}, David A Pirman³, Olga Zaslaver², Gromoslaw A Smolen^{6

7}, Zhen-Yuan Lin⁸, Cassandra J Wong⁸, Charles Boone^{1

2}, Anne-Claude Gingras^{1

8}, J Rafael Montenegro-Burke^{1

2}, Jason Moffat^{9

10

11

12}

¹ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
² Donnelly Centre, Toronto, ON, Canada.
³ Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
⁴ Canadian Nuclear Laboratories, Chalk River, ON, Canada.
⁵ Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
⁶ Agios Pharmaceuticals, Cambridge, MA, USA.
⁷ Celsius Therapeutics, Cambridge, MA, USA.
⁸ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
⁹ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. jason.moffat@sickkids.ca.
¹⁰ Donnelly Centre, Toronto, ON, Canada. jason.moffat@sickkids.ca.
¹¹ Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada. jason.moffat@sickkids.ca.
¹² Institute for Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada. jason.moffat@sickkids.ca.

^# Contributed equally.

No abstract available

Publication types